ArticleFrontiers in cardiovascular medicine2023
Should GDMT be prioritized over revascularization in new onset HFrEF? Potential lessons from the REVIVED-BCIS2 and STRONG-HF trials.
Neal M Dixit et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.